Dr. Mark Weidenbaum, MD

Dr. Weidenbaum practices at ColumbiaDoctors Midtown in New York, New York.

Dr. Weidenbaum's NPI, 1538193636, was assigned on July 11, 2006. Dr. Weidenbaum graduated from Columbia University Vagelos College of Physicians and Surgeons in 1981. Dr. Weidenbaum holds New York license 151703.

Dr. Weidenbaum's primary practice is ColumbiaDoctors Midtown, at 51 West 51st Street, New York, NY 10019. The practice phone is (212) 326-8514.

Dr. Weidenbaum's primary practice is ColumbiaDoctors Midtown in New York, New York. Dr. Weidenbaum is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Weidenbaum to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weidenbaum practices, 6 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Weidenbaum's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Weidenbaum is licensed in New York.

Dmand AI lists lower back pain, neck pain and spine problems, scoliosis, tendon and ligament injury and thoracic spine disorders among the conditions Dr. Weidenbaum treats.

CMS data shows 248 Medicare services from Dr. Weidenbaum across 3 procedure codes in 2024, all of them office visits, for 200 Medicare patients. Medicare paid $30,685 for them. Every service was in an office.

CMS counts 200 Medicare patients who saw Dr. Weidenbaum in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have arthritis, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Weidenbaum's median patient age at 63, with 60% women.

In 2024, Dr. Weidenbaum wrote 39 Medicare Part D claims for 23 patients. 100% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $17 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Weidenbaum for performance year 2024, reported through an alternative payment model (APM). Dr. Weidenbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weidenbaum as offering telehealth.

Dmand AI links 14 papers to Dr. Weidenbaum, published from 2008 to 2023. 2008 was the busiest year, with 2. The most frequent topics are Lumbar Vertebrae, Spine and Cadaver. Dr. Weidenbaum has published most often in Spine (Phila Pa 1976). Dr. Weidenbaum's most frequent co-authors are Ronald Arthur Lehman, MD, Lawrence G. Lenke, MD and Zeeshan Mohammad Sardar, MD.

CMS Open Payments shows 20 general payments to Dr. Weidenbaum from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 93% of the total. Spinecraft, LLC paid the most, $24,000.

Dmand AI lists 1 award for Dr. Weidenbaum, most recently CMS Stage 1 2012 in 2012.

Dr. Weidenbaum graduated from Columbia University Vagelos College of Physicians and Surgeons in 1981.

Dr. Weidenbaum is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.